PMID: 6106148Sep 1, 1980Paper

Beta blockade and diabetes mellitus: effect of oxprenolol and metoprolol on the metabolic, cardiovascular, and hormonal response to insulin-induced hypoglycemia in normal subjects

Metabolism: Clinical and Experimental
G C VibertiS R Bloom

Abstract

In a double-blind randomized study, the effect of the acute administration of a single oral dose of oxprenolol, a nonselective beta-blocker, and of metoprolol, a beta 1 selective blocker, on insulin-induced hypoglycemia was tested in seven normal subjects. Neither of the drugs potentiated the hypoglycemic effect of insulin. The recovery from hypoglycemia was delayed by both blocking agents only in the late phases of the experimental observation. This effect could not be accounted for by suppression of release of the counterregulatory hormones glucagon or cortisol, but may be mediated by the inhibition of NEFA and gluconeogenic-substrate release in response to hypoglycemia. Both drugs blocked the hypoglycemia-induced tachycardia. Only oxprenolol raised diastolic blood pressure during hypoglycemia. Symptoms of hypoglycemia were not masked by either blocking agent, and sweating was enhanced and prolonged by both drugs. Thus, no clear-cut differences in the glycemic response to insulin-induced hypoglycemia were found between metoprolol and oxprenolol, but the drugs differed in their influence upon the blood pressure response to insulin-induced hypoglycemia.

Associated Clinical Trials

May 22, 2017·Anu SharmaAnu Sharma

References

Jul 31, 1976·British Medical Journal·S P Deacon, D Barnett
Oct 9, 1976·British Medical Journal·S P LintonM J Kendall
Jan 1, 1977·Scottish Medical Journal·N M DavidsonE B French
Sep 24, 1977·British Medical Journal·S P Deacon
Apr 30, 1977·Lancet·J Feely
Feb 1, 1976·Metabolism: Clinical and Experimental·J W EnsinckR G Campbell
Jun 1, 1976·British Journal of Clinical Pharmacology·M J WestE B Faragher
Jan 1, 1975·Acta diabetologica latina·F MassaraG Molinatti
Feb 1, 1976·The Journal of Clinical Investigation·J P PalmerJ W Ensinck
Nov 1, 1974·The Journal of Clinical Investigation·R M WalterJ W Ensinck
Jan 14, 1967·Lancet·T F Mackintosh
Dec 24, 1966·Lancet·M N KotlerA H Rubenstein
Mar 4, 1967·Lancet·T Simpson
Apr 27, 1968·Lancet·W S Reveno, H Rosenbaum
Jul 1, 1970·Metabolism: Clinical and Experimental·W G Blackard, G J Hubbell
Dec 27, 1973·Clinica Chimica Acta; International Journal of Clinical Chemistry·M Carruthers, D A Young
Jun 3, 1972·British Medical Journal·R Wray, S B Sutcliffe

❮ Previous
Next ❯

Citations

Mar 6, 2007·European Journal of Applied Physiology·A ViruA C Hackney
Jan 1, 1991·Life Sciences·M G ClarkE Q Colquhoun
Jan 1, 1990·Pharmacology & Therapeutics·T H Pringle, J G Riddell
Aug 1, 1987·The Journal of Clinical Investigation·S AttvallU Smith
Jun 1, 1986·Metabolism: Clinical and Experimental·D ThorinR A DeFronzo
Jul 20, 1983·The American Journal of Cardiology·W J LouisO H Drummer
Jun 1, 2017·Hypertension·Tetsuro TsujimotoHiroshi Kajio
Mar 1, 1989·British Journal of Sports Medicine·B H Jacobson, F A Kulling
Jun 1, 1992·Journal of Clinical Pharmacy and Therapeutics·C A Haffner, M J Kendall
Jul 28, 2016·Diabetes Care·Tetsuro TsujimotoHiroshi Kajio
Jan 1, 1983·Acta Medica Scandinavica. Supplementum·I Lager

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.